# Interleukin-2 in Treating Patients With Mycosis Fungoides or Sezary Syndrome

> **NCT00005788** · PHASE2 · TERMINATED · sponsor: **Northwestern University**

## Conditions studied

- Lymphoma

## Interventions

- **BIOLOGICAL:** aldesleukin

## Key facts

- **NCT ID:** NCT00005788
- **Lead sponsor:** Northwestern University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 1997-04
- **Primary completion:** 2002-01
- **Final completion:** 2002-01
- **Target enrollment:** — (—)
- **Why stopped:** Low/inadequate rate of accrual.
- **Last updated:** 2012-06-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00005788

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00005788, "Interleukin-2 in Treating Patients With Mycosis Fungoides or Sezary Syndrome". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00005788. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*